このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Alkem Laboratories 将来の成長
Future 基準チェック /26
Alkem Laboratories利益と収益がそれぞれ年間13.6%と9.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に17.3% 13.4%なると予測されています。
主要情報
13.6%
収益成長率
13.1%
EPS成長率
| Pharmaceuticals 収益成長 | 17.1% |
| 収益成長率 | 9.6% |
| 将来の株主資本利益率 | 17.2% |
| アナリストカバレッジ | Good |
| 最終更新日 | 26 Jun 2024 |
今後の成長に関する最新情報
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Recent updates
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Feb 08Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?
Jan 09Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Nov 30Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly
Nov 17I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut
Sep 07Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise
Aug 20Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00
Aug 03Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Jul 19Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jul 01業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 3/31/2027 | 169,447 | 26,442 | 18,721 | 23,969 | 10 |
| 3/31/2026 | 154,532 | 24,867 | 16,473 | 21,712 | 21 |
| 3/31/2025 | 139,911 | 21,453 | 11,729 | 22,294 | 21 |
| 3/31/2024 | 126,676 | 17,958 | 16,888 | 19,481 | N/A |
| 12/31/2023 | 126,344 | 15,732 | N/A | N/A | N/A |
| 9/30/2023 | 123,514 | 14,329 | 18,370 | 20,537 | N/A |
| 6/30/2023 | 119,906 | 11,433 | N/A | N/A | N/A |
| 3/31/2023 | 115,993 | 9,842 | 14,496 | 16,825 | N/A |
| 12/31/2022 | 111,805 | 10,208 | N/A | N/A | N/A |
| 9/30/2022 | 107,586 | 10,917 | 5,527 | 8,426 | N/A |
| 6/30/2022 | 104,792 | 13,051 | N/A | N/A | N/A |
| 3/31/2022 | 106,342 | 16,456 | 7,721 | 11,110 | N/A |
| 12/31/2021 | 103,425 | 17,780 | N/A | N/A | N/A |
| 9/30/2021 | 100,416 | 17,033 | 10,478 | 13,213 | N/A |
| 6/30/2021 | 96,044 | 16,311 | N/A | N/A | N/A |
| 3/31/2021 | 88,650 | 15,850 | 11,051 | 12,649 | N/A |
| 12/31/2020 | 87,218 | 15,338 | N/A | N/A | N/A |
| 9/30/2020 | 85,971 | 14,648 | 8,916 | 11,455 | N/A |
| 6/30/2020 | 84,984 | 13,636 | N/A | N/A | N/A |
| 3/31/2020 | 83,444 | 11,271 | 2,220 | 5,851 | N/A |
| 12/31/2019 | 81,484 | 11,057 | N/A | N/A | N/A |
| 9/30/2019 | 78,929 | 9,262 | 5,173 | 8,756 | N/A |
| 6/30/2019 | 75,478 | 8,098 | N/A | N/A | N/A |
| 3/31/2019 | 73,572 | 7,605 | 2,505 | 7,797 | N/A |
| 12/31/2018 | 70,157 | 6,602 | N/A | N/A | N/A |
| 9/30/2018 | 68,318 | 6,293 | N/A | N/A | N/A |
| 6/30/2018 | 67,788 | 6,955 | N/A | N/A | N/A |
| 3/31/2018 | 63,918 | 6,309 | -4,177 | 2,660 | N/A |
| 12/31/2017 | 60,044 | 7,009 | N/A | N/A | N/A |
| 9/30/2017 | 57,285 | 7,626 | N/A | N/A | N/A |
| 6/30/2017 | 55,019 | 7,248 | N/A | N/A | N/A |
| 3/31/2017 | 56,875 | 8,920 | N/A | 4,711 | N/A |
| 12/31/2016 | 56,933 | 7,732 | N/A | N/A | N/A |
| 9/30/2016 | 54,992 | 7,267 | N/A | N/A | N/A |
| 6/30/2016 | 52,419 | 7,108 | N/A | N/A | N/A |
| 3/31/2016 | 49,248 | 7,416 | N/A | 7,258 | N/A |
| 12/31/2015 | 47,975 | 8,189 | N/A | N/A | N/A |
| 9/30/2015 | 44,556 | 7,227 | N/A | 4,023 | N/A |
| 6/30/2015 | 40,459 | 5,781 | N/A | N/A | N/A |
| 3/31/2015 | 37,434 | 3,916 | N/A | 3,255 | N/A |
| 3/31/2014 | 31,191 | 4,353 | N/A | 2,900 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ALKEMの予測収益成長率 (年間13.6% ) は 貯蓄率 ( 6.7% ) を上回っています。
収益対市場: ALKEMの収益 ( 13.6% ) Indian市場 ( 16% ) よりも低い成長が予測されています。
高成長収益: ALKEMの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: ALKEMの収益 ( 9.6% ) Indian市場 ( 9.5% ) よりも速いペースで成長すると予測されています。
高い収益成長: ALKEMの収益 ( 9.7% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: ALKEMの 自己資本利益率 は、3年後には低くなると予測されています ( 17.3 %)。